NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Grants > Search Current & Recent Grants > Cost-effectiveness of Early vs. Delayed Antiretroviral Therapy in Haiti Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

Cost-effectiveness of Early vs. Delayed Antiretroviral Therapy in Haiti

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

International Research Scientist Development Award (IRSDA)

Project Information in NIH RePORTER

Cost-effectiveness of Early vs. Delayed Antiretroviral Therapy in Haiti

Principal Institution

Brigham and Women's Hospital

Principal Investigator(s) (PI)

Koenig, Serena Patricia

Project Contact Information

Email: skoenig@partners.org

Year(s) Awarded

2004-2012

Collaborating Country

Haiti

NIH Partners

NIMHD

Related World Regions / Countries